These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of 131I in the treatment of well differentiated thyroid cancer. Woodrum DT; Gauger PG J Surg Oncol; 2005 Mar; 89(3):114-21. PubMed ID: 15719384 [TBL] [Abstract][Full Text] [Related]
25. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926 [TBL] [Abstract][Full Text] [Related]
26. Controversy over radioiodine ablation in thyroid cancer: who benefits? Yoo DC; Noto RB; Mazzaglia PJ Surg Clin North Am; 2014 Jun; 94(3):573-86. PubMed ID: 24857577 [TBL] [Abstract][Full Text] [Related]
27. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
28. Drug therapy alternatives in the treatment of thyroid cancer. O'Doherty MJ; Coakley AJ Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595 [TBL] [Abstract][Full Text] [Related]
30. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. Mallick U; Harmer C; Hackshaw A Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):325-6. PubMed ID: 18474322 [No Abstract] [Full Text] [Related]
31. Association between quality of life and patient-reported complications from surgery and radioiodine in early-stage thyroid cancer survivors: A matched-pair analysis. Chow KY; Kurumety S; Helenowski IB; Giri S; Sturgeon C Surgery; 2021 Aug; 170(2):462-468. PubMed ID: 33648765 [TBL] [Abstract][Full Text] [Related]
32. [Role of iodine-131 in the management of differentiated thyroid cancers (vesicular origin)]. Boughattas S; Hassine H; Chatti K; Letaief B; Jomaa R; Essabbah H Tunis Med; 2002 Aug; 80(8):434-44. PubMed ID: 12703121 [TBL] [Abstract][Full Text] [Related]
33. International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer. Kraft O; Reznák I Nucl Med Rev Cent East Eur; 2006; 9(1):84-8. PubMed ID: 16791814 [TBL] [Abstract][Full Text] [Related]
34. Radioiodine ablation for differentiated thyroid cancer-none, one dose or two? Rees GJ Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):131-5. PubMed ID: 19969444 [TBL] [Abstract][Full Text] [Related]
36. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210 [TBL] [Abstract][Full Text] [Related]
37. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma. Kim EY; Kim TY; Kim WG; Yim JH; Han JM; Ryu JS; Hong SJ; Yoon JH; Gong G; Kim WB; Shong YK Nucl Med Commun; 2011 Oct; 32(10):954-9. PubMed ID: 21849927 [TBL] [Abstract][Full Text] [Related]
38. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. Sawka AM; Thephamongkhol K; Brouwers M; Thabane L; Browman G; Gerstein HC J Clin Endocrinol Metab; 2004 Aug; 89(8):3668-76. PubMed ID: 15292285 [TBL] [Abstract][Full Text] [Related]